<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00913042</url>
  </required_header>
  <id_info>
    <org_study_id>CRC 06021</org_study_id>
    <nct_id>NCT00913042</nct_id>
  </id_info>
  <brief_title>Assessment of New Blood Culture Methods on the Microbiological Documentation of Febrile Neutropenia</brief_title>
  <acronym>HEMATOCPLUS</acronym>
  <official_title>Assessment of New Blood Culture Methods on the Microbiological Documentation of Febrile Neutropenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Febrile neutropenia are microbiologically documented in only 30% of the cases, and almost
      exclusively by blood cultures. The reasons for this low documentation are likely multiple:
      (1) some of these fevers are of non-infectious origin. (2) The bacterial inoculum present in
      the blood may be low and consequently undetectable by conventional blood cultures.

      The primary objective of the study is to assess new blood culture procedures and technics, in
      order to improve the diagnostic yield of blood cultures during febrile neutropenic episodes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluation criteria are 1) proportion of microbiologically documented infections 2) time
      elapsed from bed side sampling to microbiological diagnostic, in case of positive sample.

      The assessed procedures included a large volume of blood, an early incubation made possible
      by the availability of a culture device in the hematology department, an early warning in
      case of positive blood culture, bacterial DNA detection in blood, and an early identification
      of the positive strains and their resistance profile.

      We hypothesize that the combination of these different procedures will improve the proportion
      of microbiologically blood culture from 30 to 45%. One hundred and 20 episodes of febrile
      neutropenia are necessary to achieve this goal.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">April 2009</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>proportion of microbiologically documented infections</measure>
    <time_frame>Day 14 from inclusion</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>clinical status at the end of hospitalisation</measure>
    <time_frame>Day 30 from inclusion</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">120</enrollment>
  <condition>Febrile</condition>
  <condition>Neutropenia</condition>
  <condition>Post-chemotherapy</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>febrile neutropenia patient</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>sample blood</intervention_name>
    <description>Early culture
Bacterial DNA tests in blood</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      bacterial inoculum in the blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Febrile neutropenia post-chemotherapy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 18 y

          -  first episode of febrile neutropenia during a given neutropenic phase

          -  PMN &lt; 500/mm3, chemotherapy-induced

          -  fever &gt; 38°C twice, or &lt; 38°3C once

          -  signed informed consent

        Exclusion Criteria:

        - patient already receiving empirical or therapeutic antibacterial after their first
        episode of febrile neutropenia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cécile Pautas, PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Henri Mondor Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hematology Department, Paris 12 University Hospital Henri Mondor</name>
      <address>
        <city>Creteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 2, 2009</study_first_submitted>
  <study_first_submitted_qc>June 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2009</study_first_posted>
  <last_update_submitted>July 25, 2012</last_update_submitted>
  <last_update_submitted_qc>July 25, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 26, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Febrile neutropenia</keyword>
  <keyword>Blood culture</keyword>
  <keyword>Bacteremia</keyword>
  <keyword>Bacterial DNA testing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neutropenia</mesh_term>
    <mesh_term>Fever</mesh_term>
    <mesh_term>Febrile Neutropenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

